Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously and managed expectantly by monitoring the patient's complete blood count. Over several months ...

(SLRX), a clinical-stage biopharmaceutical company ... treatment of myelodysplastic syndrome or MDS and chronic myelomonocytic leukemia or CMML. The trial, conducted at the University of Texas ...